Powered by Google Google ÜbersetzerGoogle Übersetzer
Originaltext
Diese Übersetzung bewerten
Mit deinem Feedback können wir Google Übersetzer weiter verbessern
Latest Press Releases
View all
TimeHeadline
8h agoDelivery Hero confirms approach by Uber Technologies’ with respect to potential takeover offer
9h agoRefers to Item 7 on the agenda: Report on the audit of the consolidated financial statements of Grupa Kęty SA
11h agoThe 4th BOCHK Science and Technology Innovation Prize Award Ceremony Concludes with Great Success
19h agoBuffalo Potash Files Annual Information Form and New Technical Report
20h agoIonik Announces 30-Day Extension of Senior Debt Facility
Abeona Therapeutics Inc. logo

Abeona Therapeutics Inc.

About

5.44USD-0.08 -1.45%
Closed • Updated at 22:39 GMT+00:00
Market Cap$310.05M
P/E Ratio5.80
Volume672.0K
Beta1.41
RSI49.81
Gross Margin34.60%
Health TechnologyPharmaceuticals: Major

Abeona Therapeutics Inc. — investor relations, events, news, and company updates on 6ix.

Latest News

May 13 2026
Abeona Therapeutics® Reports First Quarter 2026 Results and Provides Pipeline Update
May 11 2026
Abeona Therapeutics® Announces Activation of Children's Hospital of Philadelphia as a New Qualified Treatment Center for ZEVASKYN®
May 4 2026
Abeona Therapeutics® Announces Date of First Quarter Financial Results
Apr 7 2026
Abeona Therapeutics® Announces Appointment of Keith A. Goldan to its Board of Directors
Apr 2 2026
Abeona Therapeutics® Announces New Qualified Treatment Center for ZEVASKYN® in New York

Community Chat

Ask AI

Try asking
6ix6ixAIEvents